EHA: Early metabolic response determination by FDG-PET allows substantial reduction of chemo and toxicity for advanced stage Hodgkin lymphoma
Hodgkin lymphoma is the most common malignancy of young adults. Intensive chemotherapy with 8 or…
Browsing: Lymphoma
ASCO 2017: Steady decrease in severe health problems for childhood cancer survivors
Treatments for childhood cancer are often intense and carry the risk of lifelong health problems…
Second cancers deadlier in young patients
Second cancers in children and adolescents and young adults (AYA) are far deadlier than they…
Latest data show a global increase of 13% in childhood cancer incidence over two decades
An international study coordinated by the International Agency for Research on Cancer (IARC) and published…
Diversity key to better lymphoma immune response
A University of Queensland researcher has found patients with non-hodgkins lymphoma are most likely to…
Nine US deaths linked to breast implant-associated cancer
Nine women are believed to have died in the United States from a rare cancer…
New research shows how metabolism and epigenetics play a role in cancer development
Pioneering experiments half a century ago showed that chemical modification affecting the packaging of our…
Preterm births more common in mothers who are cancer survivors
For young women facing a new cancer diagnosis, fertility preservation can be an important consideration…
Hodgkin lymphoma survivors at high risk of second cancers
Patients who are cured of Hodgkin lymphoma are at a high risk of developing a…
Combination of ground-breaking treatments offer powerful new path for blood cancer therapies
Researchers have identified for the first time how a new class of epigenetic drug engages with…